SCHEMBL6779237

SCHEMBL6779237

O=C(NC(Cc1ccccc1-c1ccccc1)c1cccnc1)c1sc2ccccc2c1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RXFP1 Q9HBX9 5/20 0.50
▸ NPSR1 Q6W5P4 4/20 0.50
▸ PRNP P04156 1/20 0.50
▸ ALDH1A1 P00352 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ HPGD P15428 2/20 0.48
▸ GAA P10253 1/20 0.48
▸ THRB P10828 1/20 0.48
▸ KCNA5 P22460 3/20 0.48
▸ KCNH2 Q12809 2/20 0.48
▸ MAPT P10636 2/20 0.45
▸ LMNA P02545 1/20 0.45
▸ NPC1 O15118 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ OGG1 O15527 1/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ SUCNR1 Q9BXA5 2/20 0.43
▸ CYP1A2 P05177 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6779481 0.80 KCNA5 (0.50) KCNA5KCNH2
SCHEMBL6779728 0.74 KCNA5 (0.53) KMT2AKCNA5KCNH2HTTSUCNR1
SCHEMBL6784951 0.73 KMT2A (0.44) NPSR1ALDH1A1KMT2AHPGDGAA
SCHEMBL6779240 0.72 HPGD (0.51) NPSR1ALDH1A1KMT2AHPGDGAA
SCHEMBL7673584 0.71 KCNA5 (0.48) ALDH1A1KMT2AKCNA5KCNH2MAPT
SCHEMBL11951263 0.70 TLR3 (0.76) RXFP1NPSR1PRNPALDH1A1KMT2A
SCHEMBL11951514 0.70 TLR3 (0.76) RXFP1NPSR1PRNPALDH1A1KMT2A
SCHEMBL11304525 0.70 TLR3 (0.76) RXFP1NPSR1PRNPALDH1A1KMT2A
SCHEMBL7984436 0.69 GAA (0.85) NPSR1ALDH1A1KMT2AHPGDGAA
SCHEMBL23353332 0.69 MAPT (0.74) RXFP1NPSR1ALDH1A1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein BOOTH RICHARD JOHN (US) 2002-10-24 — — US claimed
US-6780883-B2 ANTICHOLESTEROL AGENTS; CARDIOVASCULAR DISORDERS; ANTILIPEMIC AGENTS; RESTENOSIS; DIETETICS WARNER-LAMBERT COMPANY 2004-08-24 — — US disclosed
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein BOOTH RICHARD JOHN (US) 2002-10-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein CETP, MTTP, LCAT RXFP1 2342/4885NPSR1 3567/4885PRNP 4827/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback